Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era

PURPOSE: Systemic chemotherapy is the only option for patients with unresectable/metastatic hepatocellular carcinoma (HCC) who are not candidates for local/regional treatment. However, the response to such treatment and survival are poor, especially in hepatitis B virus (HBV) endemic areas. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Nae Yu, Sun, Jong Mu, Kim, Yu-Jung, Lee, Keun-Wook, Kim, Jee Hyun, Bang, Soo-Mee, Kim, Jin-Wook, Jeong, Sook-Hyang, Lee, Jong Seok
Formato: Texto
Lenguaje:English
Publicado: Korean Cancer Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021739/
https://www.ncbi.nlm.nih.gov/pubmed/21253322
http://dx.doi.org/10.4143/crt.2010.42.4.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021739/
https://www.ncbi.nlm.nih.gov/pubmed/21253322
http://dx.doi.org/10.4143/crt.2010.42.4.203

Ejemplares similares